Track ResMed Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

ResMed Inc. RMEA.F · Stock Open ResMed Inc. in new tab

19.50 EUR
P/E
21.91
EPS
0.89
Yield
1.15%
P/B
1.98
ROE
24.27
Beta
0.75
Loading chart...
Key Metrics
P/E21.91
EPS0.89
Book Value9.86
Price to Book1.98
Debt/Equity12.54
Growth
Revenue Growth0.09%
Earnings Growth0.02%
Dividend
Dividend Yield1.15%
Annual dividends0.23 EUR
Ex-Div. DateAug. 19, 2026
Payout23.01%
5y avg Yield0.88%

DCF Valuation

Tweak assumptions to recompute fair value for ResMed Inc. (RMEA.F)
Currency: EUR
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

ResMed Inc. Logo ResMed Inc. Analysis (RMEA.F)

United States Health Care Official Website Stock

Is ResMed Inc. a good investment? ResMed Inc. (RMEA.F) is currently trading at 19.50 EUR.

In terms of valuation, the stock trades at a P/E ratio of 21.91. This valuation is generally in line with the broader market.

For income investors, ResMed Inc. pays a dividend yield of 1.15%. With a payout ratio of 23%, the dividend appears sustainable.

Investor FAQ

Does ResMed Inc. pay a dividend?

Yes, it pays an annual dividend of 0.23 EUR (1.15% yield).

What asset class is ResMed Inc.?

ResMed Inc. is classified as a Stock. You can compare it against 13 other assets in the "Related Symbols" list on this page.

Company Profile

ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. It also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Exchange Ticker
ASX (Australia) RMD.AX
PNK (United States) RSMDF
MEX (Mexico) RMD.MX
VIE (Austria) RMD.VI
FRA (Germany) RMD.F
BER (Germany) RME.BE
STU (Germany) RME.SG
DUS (Germany) RME.DU
FRA (Germany) RME.F
FRA (Germany) RMEA.F
MUN (Germany) RME.MU
STU (Germany) RMEA.SG
SAO (Brazil) R1MD34.SA
Trades
Dividend Yield
1.15%
5y avg 0.88%
Annual Dividends
0.23EUR
Next Ex. Div Date
Aug. 19, 2026
Payout Ratio
23.01%
Dividend History paid per year (EUR)
Historical Dividends
Year Total Dividends
2027
0.17 EUR
Aug. 11, 2027 (estimated) 0.0612
May 12, 2027 (estimated) 0.0552
Feb. 10, 2027 (estimated) 0.0543
2026
0.22 EUR
Nov. 11, 2026 (estimated) 0.0556
Aug. 19, 2026 0.0567
May 13, 2026 0.0515
Feb. 11, 2026 0.0515
2025
0.19 EUR
Nov. 12, 2025 0.0515
Aug. 13, 2025 0.0515
May 7, 2025 0.0455
Feb. 12, 2025 0.0455
2024
0.17 EUR
Nov. 6, 2024 0.0455
Aug. 14, 2024 0.0455
May 8, 2024 0.0412
Feb. 7, 2024 0.0412
2023
0.16 EUR
Nov. 8, 2023 0.0412
Aug. 16, 2023 0.0412
May 10, 2023 0.0378
Feb. 8, 2023 0.0378
2022
0.15 EUR
Nov. 9, 2022 0.0378
Aug. 17, 2022 0.0378
May 11, 2022 0.0361
Feb. 9, 2022 0.0361
2021
0.14 EUR
Nov. 10, 2021 0.0361
Aug. 18, 2021 0.0361
May 12, 2021 0.0335
Feb. 10, 2021 0.0335
2020
0.10 EUR
Nov. 11, 2020 0.0335
Aug. 19, 2020 0.0335
Feb. 12, 2020 0.0335
2019
0.07 EUR
Nov. 6, 2019 0.0335
Aug. 14, 2019 0.0335
2018
0.06 EUR
May 9, 2018 0.0300
Feb. 7, 2018 0.0300
2017
0.08 EUR
Nov. 8, 2017 0.0300
Aug. 16, 2017 0.0189
May 10, 2017 0.0283
2015
0.04 EUR
May 19, 2015 0.0186
Feb. 10, 2015 0.0190
2014
0.07 EUR
Nov. 18, 2014 0.0168
Aug. 19, 2014 0.0158
May 16, 2014 0.0167
Feb. 13, 2014 0.0215
2013
0.05 EUR
Nov. 13, 2013 0.0139
Aug. 14, 2013 0.0145
May 15, 2013 0.0107
Feb. 13, 2013 0.0087
2012
0.02 EUR
Nov. 14, 2012 0.0086
Sept. 3, 2012 0.0102
Upcoming Dividends
Name Payment Date Status Amount
ResMed Inc. Aug 19, 2026 0.056661 EUR
ResMed Inc. May 13, 2026 0.05151 EUR
ResMed Inc. Feb 11, 2026 0.05151 EUR
ResMed Inc. Nov 12, 2025 0.05151 EUR
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion